GOLM1 and hepatocellular carcinoma: These findings suggest that the three markers panel (GP73, MDK and DKK-1) with or without AFP could improve the diagnostic efficacy for discriminating HCC patients from cirrhotic and non-cirrhotic hepatitis C virus carriers.